Anders Fomsgaard, virus researcher and chief physician at SSI, Statens Serum Institut, tells TV2 that there are now 11 cases of B1617 in Denmark, and that they are all connected to countries where the variant is already known. “So there are not 11 different chains of infection and that reassures us. It would not have been so good,” he says.
Denmark has received the first claim for compensation for a death caused by a special type of blood clot, which the authorities link with the Astrazeneca vaccine. The patient compensation scheme has received a total of 29 compensation applications from citizens who have received the Astrazeneca vaccine. A further eight cases concern the Pfizer vaccine. There are no claims for Moderna.
This is stated by Patienterstatningen, which handles cases of compensation for citizens who are affected by serious side effects from e.g. medicines.
After her first vaccination with Astrazeneca, the 43-year-old nurse Tina Sylvester Rohrmann from Nyborg was hit by blood clots in her lungs. She is sure that there is a connection with the vaccine. The doctors at OUH in Svendborg think the same, she says. The Funen nurse fully supports vaccines. Just not the one from Astrazeneca.
Avisendanmark report (paywall)
“We are dealing with a whole new syndrome, called WHITE. We have identified that there is an increased risk in using the vaccine. It gives us a figure on the increased risk with the serious disease cases. About 1 in 40,000 of those vaccinated with AstraZeneca’s vaccine are affected and many die,” says Søren Brostrøm.
“We know a lot more today than we did a month ago. We know that there is a possible biological explanation why AstraZeneca’s vaccine may cause these cases. This suggests a cross-reaction. We know that there is a temporal connection – we see cases 8-10 days after the vaccination, «says Søren Brostrøm, who gradually feels on safe scientific grounds when he now puts into words the Danish decision to stop using the vaccine.
Stunning developments today in relation to the adenovirus vaccines now being marketed for Covid-19, including AstraZeneca’s Vaxevria, and the Johnson and Johnson Covid-19 vaccine. Are adenovirus vaccines now finished?
- The EU Commission has decided not to renew COVID-19 vaccine contracts with AstraZeneca and Johnson & Johnson – Reuters
- AstraZeneca vaccine: Denmark stops rollout completely – BBC report
- EMA to provide further context on risk of very rare blood clots with low blood platelets – EMA
- U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clot – Reuters
Our opinion: The writing is on the wall for adenovirus vaccines as far as the Sars-cov-2 pandemic is concerned
The task of digging up Denmark’s 17 million culled mink and burning them has been put out to tender. According to the Danish Waste Association, 13 plants across the country have shown interest in bidding for the project.
“Someone has to do it, and since we have the capacity for it, we can just as well bid”, says the North Jutland waste company’s chairman Kristoffer Hjort Storm”.
One of them is the North Jutland company, which according to the chairman of the board can probably receive 60 tonnes of dead animals a day in the form of two wagon loads. “We have decided that the trucks that are to come to Aalborg with the minks must arrive outside our normal opening hours. Then they come directly in and load the minks into our silo, where they are mixed with other waste,” says Kristoffer Hjort Storm.
While the driver may have to keep his nose shut when unloading the dead animals, according to the chairman of the board, it will not give rise to odor nuisances for the citizens. “The minks are burned at high temperatures, and we have many procedures for cleaning the smoke. There will be no odor nuisance from the smoke. We are completely convinced of that,” says Kristoffer Hjort Storm.
The North Jutland waste company also burned a small amount of dead mink back in November, when the decision to kill all mink had been made.
A trial burning of the minks is expected to take place in mid-May. If everything goes according to plan, the burning of the minks will take place continuously from the end of May until July.
The European Court of Human Rights ruled on Thursday that democratic governments can make vaccinations obligatory, in a landmark judgement rejecting complaints brought by Czech families penalised for refusing compulsory jabs for their children.
“The… measures could be regarded as being ‘necessary in a democratic society'” the court ruled, saying that the Czech health policy was consistent with the “best interests” of children.
Our opinion: ** Is there an easier or quicker way of antagonising parents in the middle of a global viral pandemic than encouraging mandatory vaccinations? We can’t think of one. Expect severe blowback **
A large, new survey of 117,670 people from Denmark’s Statens Serum Institut (SSI) showed that PCR tests found 4,069 positive samples but subsequent antigen tests captured only 2,159 of them. 1,910 people received a negative antigen test result, even though coronavirus could be detected in the throat.
Over a period of just over seven weeks from February 1 to March 23, 117,670 citizens received both a PCR test and an antigen test within 48 hours.
According to the PCR test, 4,069 of them were positive. However, the antigen test captured only 2,159 of them. This meant that 1,910 people received a negative test result, even though coronavirus could be detected in the throat.
“Our study shows that antigen testing is quite imprecise in identifying an infected person. We can see that 47% of all those who are actually infected with corona get a negative test result after an antigen test. So they have been tested false negative “, says acting academic director at SSI Tyra Grove Krause about the study.
Denmark has found the first two cases of the UK coronavirus variant B.1.1.7, which has been mutated to have reduced sensitivity to antibodies, says Minister of Health Magnus Heunicke (S).
The variant is immediately the same as the one commonly referred to as B117 – the British variant of coronavirus – but it has the mutation E484K.
According to the Statens Serum Institut (SSI), the E484K mutation has so far only been seen in the B117 variant in the UK and the Netherlands.
The text of the following statement was released by the Governments of the United States of America, Australia, Canada, Czechia, Denmark, Estonia, Israel, Japan, Latvia, Lithuania, Norway, the Republic of Korea, Slovenia, and the United Kingdom.
The Governments of Australia, Canada, Czechia, Denmark, Estonia, Israel, Japan, Latvia, Lithuania, Norway, the Republic of Korea, Slovenia, the United Kingdom, and the United States of America remain steadfast in our commitment to working with the World Health Organization (WHO), international experts who have a vital mission, and the global community to understand the origins of this pandemic in order to improve our collective global health security and response. Together, we support a transparent and independent analysis and evaluation, free from interference and undue influence, of the origins of the COVID-19 pandemic. In this regard, we join in expressing shared concerns regarding the recent WHO-convened study in China, while at the same time reinforcing the importance of working together toward the development and use of a swift, effective, transparent, science-based, and independent process for international evaluations of such outbreaks of unknown origin in the future.
The mission of the WHO is critical to advancing global health and health security, and we fully support its experts and staff and recognize their tireless work to bring an end to the COVID-19 pandemic, including understanding how the pandemic started and spread. With such an important mandate, it is equally essential that we voice our shared concerns that the international expert study on the source of the SARS-CoV-2 virus was significantly delayed and lacked access to complete, original data and samples. Scientific missions like these should be able to do their work under conditions that produce independent and objective recommendations and findings. We share these concerns not only for the benefit of learning all we can about the origins of this pandemic, but also to lay a pathway to a timely, transparent, evidence-based process for the next phase of this study as well as for the next health crises.
We note the findings and recommendations, including the need for further studies of animals to find the means of introduction into humans, and urge momentum for expert-driven phase 2 studies. Going forward, there must now be a renewed commitment by WHO and all Member States to access, transparency, and timeliness. In a serious outbreak of an unknown pathogen with pandemic potential, a rapid, independent, expert-led, and unimpeded evaluation of the origins is critical to better prepare our people, our public health institutions, our industries, and our governments to respond successfully to such an outbreak and prevent future pandemics. It is critical for independent experts to have full access to all pertinent human, animal, and environmental data, research, and personnel involved in the early stages of the outbreak relevant to determining how this pandemic emerged. With all data in hand, the international community may independently assess COVID-19 origins, learn valuable lessons from this pandemic, and prevent future devastating consequences from outbreaks of disease.
We underscore the need for a robust, comprehensive, and expert-led mechanism for expeditiously investigating outbreaks of unknown origin that is conducted with full and open collaboration among all stakeholders and in accordance with the principles of transparency, respect for privacy, and scientific and research integrity. We will work collaboratively and with the WHO to strengthen capacity, improve global health security, and inspire public confidence and trust in the world’s ability to detect, prepare for, and respond to future outbreaks.
The number of inpatients increases by eight to 200 in the last 23 hours, according to figures from the Statens Serum Institut (SSI). Out of the 200 admitted patients, 27 receive help from a respirator, while 43 are in an intensive care unit. This means that approximately every fifth inpatient is in intensive care.
Due to the vaccination program, there are fewer elderly people who are hospitalized with coronavirus. This means that the inpatients have generally become younger, which is positive, as the younger ones usually have a milder admission process.
The Danish Minister of Health Magnus Heunicke: “Findings of 6 new cases with P.1, ie. a total of 9 cases. We have two new chains of infection that are neither connected to each other nor already known chain of infection. The source of the infection is unknown, and there is no known link to travel activity”
Fund af 6 nye tilfælde med P.1, dvs. i alt 9 tilfælde. Vi har to nye smittekæder, som hverken er forbundet med hinanden eller allerede kendt smittekæde. Smittekilden er ukendt, og der er ikke kendt kobling til rejseaktivitet. Intensiv smitteopsporing/isolation igangsat #COVID19dk
— Magnus Heunicke (@Heunicke) March 27, 2021
The pause for vaccination with the COVID-19 vaccine from AstraZeneca is extended by 3 weeks
The Danish Health and Medicines Authority is extending the break with the COVID-19 vaccine from AstraZeneca, because the assessment of the use of the vaccine in the Danish vaccination program against COVID-19 is still ongoing.
The National Board of Health suspended vaccination with the COVID-19 vaccine from AstraZeneca on 11 March 2021 on the basis of reports of several serious cases of blood clots, decreased platelet counts and bleeding. Subsequently, the European Medicines Agency, EMA, has assessed 25 cases of this and similar types of serious, rare side effects.
On 18 March 2021, the EMA assessed that a link between the COVID-19 vaccine from AstraZeneca and the occurrence of rare but severe cases of blood clots cannot be ruled out.
“We have started several studies and talked to experts in the affected areas, so we are sure to uncover the scope and the possible connection. This, together with EMA’s assessments, must provide a solid basis for assessing the vaccine from AstraZeneca,”says director Søren Brostrøm.
The National Board of Health receives ongoing feedback on the ongoing studies, but it is still too early to draw final conclusions.
“At present, we believe that our basis for making a final decision on the further use of the COVID-19 vaccine from AstraZeneca is too uncertain. Many studies have been launched, but we do not yet have any conclusions. That is why we have decided to extend the break,”says director Søren Brostrøm.
Is it really the way in which the AstraZeneca vaccines have been given that has triggered the deadly blood clots in several people in Europe? Chief physician and professor Niels Høiby suspects this.
“It may explain the few cases where it has gone completely wrong,” he says.
The use of AstraZeneca has now been suspended in several European countries after the deaths, including in Denmark after the death of a 60-year-old woman. But the professor of clinical microbiology at Rigshospitalet has now zoomed in on the injection itself rather than the vaccine.